跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mescaline
首页
药物
Mescaline
Mescaline
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SUBSTITUTED N-PROPYLAMINE FUSED HETEROCYCLIC MESCALINE DERIVATIVES
EP 4619391 A1
申请人: ENVERIC BIOSCIENCES CANADA INC
优先权: 2022
EP
US
WO
5 件公开
ENZYMES, POLYNUCLEOTIDES ENCODING SAME, AND METHODS OF USING SAME FOR PRODUCING MESCALINE
US 20260242834 A1
申请人: YEDA RES & DEV
优先权: 2023
US
WO
2 件公开
C1-substituted isopropylamine fused heterocyclic mescaline derivatives
US 12195439 B1
申请人: ENVERIC BIOSCIENCES CANADA INC
优先权: 2023
US
2 件公开
Substituted ethylamine fused heterocyclic mescaline derivatives
US 12492179 B2
申请人: ENVERIC BIOSCIENCES CANADA INC
优先权: 2023
US
2 件公开
Biphenyl compounds useful as muscarinic receptor antagonists
US 7560469 B2
申请人: THERAVANCE INC
优先权: 2005
US
PHARMACEUTICAL FORMULATION CONTAINING A PSYCHEDELIC SUBSTANCE OBTAINED BY 3D PRINTING BY SELECTIVE LASER SINTERING (SLS)
EP 4159202 A1
申请人: BIOMIND LABS INC
优先权: 2021
EP
PHARMACEUTICAL COMPOSITIONS COMPRISING A PSYCHEDELIC DRUG AND A DENDRITIC NANOCARRIER
EP 4417198 A1
申请人: MYOB GMBH IN GRUENDUNG
优先权: 2023
EP
METHODS FOR PREPARING MESCALINE
US 20250162980 A1
申请人: JOURNEY COLAB CORP
优先权: 2023
US
Fused heterocyclic mescaline derivatives
US 12428408 B2
申请人: ENVERIC BIOSCIENCES CANADA INC
优先权: 2023
US
药物
反馈